2019
DOI: 10.21164/pomjlifesci.609
|View full text |Cite
|
Sign up to set email alerts
|

PET – advanced nuclear imaging technology for medicine

Abstract: Positron emission tomography (PET) is currently the most advanced diagnostic imaging technology along with well-known techniques like magnetic resonance imaging (MRI) and computed tomography (CT). Tremendous technical progress in engineering, imaging and radiopharmacy has provided the basis for impressive technological advances in the field of nuclear medicine over the past 50 years. Current nuclear medicine can be divided into 2 groups: the classic, which uses gamma-cameras for single photon emission computed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…The identification of psychiatric disease entities and their relationship with organic diseases from other medical specialties (e.g., epilepsy and Parkinson's disease) as well as monitoring the treatment with synthetic drugs and potentially biologically active substances of plant origin can be completed with classical patient examination, electroencephalography, laboratory tests of biological samples, and population studies (including surveys). Special techniques currently include various ways of neuroimaging, mainly functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), which provide information about morphological changes and functional disorders occurring in depression or characteristics of diseases accompanied by depression [144][145][146][147][148][149][150][151][152][153][154].…”
Section: Neurotransmitters As the Key Pathogenetic Factorsmentioning
confidence: 99%
“…The identification of psychiatric disease entities and their relationship with organic diseases from other medical specialties (e.g., epilepsy and Parkinson's disease) as well as monitoring the treatment with synthetic drugs and potentially biologically active substances of plant origin can be completed with classical patient examination, electroencephalography, laboratory tests of biological samples, and population studies (including surveys). Special techniques currently include various ways of neuroimaging, mainly functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), which provide information about morphological changes and functional disorders occurring in depression or characteristics of diseases accompanied by depression [144][145][146][147][148][149][150][151][152][153][154].…”
Section: Neurotransmitters As the Key Pathogenetic Factorsmentioning
confidence: 99%